Pall Corp to Acquire Life Sciences Innovator ForteBio; Terms Not Disclosed
Pall Corporation (NYSE: PLL) today announced it has entered into a definitive merger agreement to acquire ForteBio®, Inc., a provider of advanced analytical systems that accelerate the discovery and development of biotech drugs. The transaction is expected to close by February of 2012.
Terms of the deal were not disclosed.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.